Medicine and Dentistry
Biological Marker
100%
Oxidative Stress
82%
Inflammatory Bowel Disease
72%
Thiol
60%
Disease
53%
Patient with Inflammatory Bowel Disease
40%
Patient with Crohn's Disease
35%
Infliximab
34%
COVID-19
33%
Disease Activity
32%
Crohn's Disease
31%
Severe Acute Respiratory Syndrome Coronavirus 2
31%
Population
31%
Ulcerative Colitis
24%
Vedolizumab
23%
Calgranulin
23%
Extracellular Matrix
23%
Prospective Cohort Study
21%
Collagen Type 4
21%
Patient with Type 2 Diabetes
19%
C Reactive Protein
18%
Collagen Type 1
16%
Treatment Response
16%
Collagen Degradation
15%
Tumor Necrosis Factor
15%
Maturity Onset Diabetes of the Young
15%
Kidney Graft
14%
Fetus Growth
14%
Chronic Kidney Disease
14%
Gut
14%
Antioxidant
13%
Hazard Ratio
13%
Iron Deficiency
12%
Neutrophil
12%
Microbiome
12%
Pathophysiology
12%
Gut Microbiota
12%
Enteritis
11%
Infection
11%
Microvascular Complication
11%
Supplementation
11%
Cardiovascular System
10%
Post-Hoc Analysis
10%
Proteomics
9%
All Cause Mortality
9%
Pre-Eclampsia
9%
Immunopathology
9%
Ascorbic Acid
9%
Cardiovascular Mortality
9%
Leukocyte Elastase
9%
Keyphrases
Free Thiols
93%
Inflammatory Bowel Disease
91%
Serum-free
55%
Systemic Oxidative Stress
54%
Oxidative Stress
46%
Crohn's Disease
39%
Oxidative Stress Markers
27%
Prospective Cohort Study
24%
Thiol Levels
21%
All-cause Mortality
21%
Plasma Calprotectin
19%
COVID-19
19%
Fecal Calprotectin
17%
Vedolizumab
17%
Induction Therapy
17%
Inflammation
17%
Hazard Ratio
16%
Disease Activity
15%
Healthy Controls
14%
New-onset Chronic Kidney Disease
14%
Zodiac
14%
Type 2 Diabetic Patients
14%
Infliximab
14%
Endoscopic Disease Activity
14%
Confidence Interval
14%
Hypertension
13%
Iron Deficiency
12%
Redox Status
12%
Cardiovascular Risk
12%
Immune Response
12%
Type I Collagen
11%
Calprotectin
11%
Eotaxin-1
11%
Antibody Signature
10%
Free Sulfhydryl
10%
C-reactive Protein
10%
Microbiome
10%
Pathophysiology
10%
Confounding Factors
9%
Biomarker Signature
9%
Methotrexate
9%
Tioguanine
9%
Thiopurines
9%
Drug Survival
9%
Gut Microbiota
9%
Intestinal Inflammation
8%
Inflammatory Biomarkers
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Ulcerative Colitis
8%
Chronic Kidney Disease
8%
Pharmacology, Toxicology and Pharmaceutical Science
Thiol
95%
Biological Marker
91%
Inflammatory Bowel Disease
68%
Crohn's Disease
65%
Disease
58%
SARS Coronavirus
32%
Calgranulin
31%
Ulcerative Colitis
25%
Coronavirinae
24%
Disease Activity
24%
Inflammation
23%
Prospective Cohort Study
21%
All Cause Mortality
20%
Non Insulin Dependent Diabetes Mellitus
19%
Collagen Type 4
19%
Infliximab
19%
Tumor Necrosis Factor
18%
Infection
17%
Pathophysiology
16%
Collagen Type 1
16%
Vedolizumab
16%
Chronic Kidney Failure
14%
Cohort Study
14%
Vaccination Policy
12%
Mercaptopurine
11%
C Reactive Protein
10%
Cardiovascular Mortality
10%
Enteritis
10%
Methotrexate
9%
Tioguanine
9%
Leukocyte Elastase
9%
Thiol Group
9%
Antioxidant
9%
Homocysteine
8%
Remission
7%
Kidney Disease
7%
Acute Kidney Failure
7%
Sepsis
7%
Immunoglobulin G Antibody
6%
Microflora
6%
Eotaxin
6%
Tolerability
6%
Adverse Event
6%
Matrix Metalloproteinase
6%
Integrin
6%
Fatty Liver
6%
Cardiovascular Disease
5%
Pharmacokinetics
5%
Syndrome
5%
Neutrophil Gelatinase Associated Lipocalin
5%
